Asan Pharm Overview

  • Founded
  • 1971
  • Status
  • Private
  • Latest Deal Type
  • Later Stage VC
  • Investors
  • 2

Asan Pharm General Information


Developer of diagnostic products intended to offer modern clinical systems. The company's products offer diagnostic reagents and lab instruments for microbiology, immunology and serology, and clinical chemistry applications as well as provides test kits for humans and animals alike cats and dogs to test influenza, dengue, TB, and syphilis, enabling users to get the test for the disease conveniently and without any trouble.

Contact Information

Formerly Known As
Sam Kwang Chemical
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Pharmaceuticals and Biotechnology
Laboratory Services (Healthcare)
Primary Office
  • 485, Cheonggyecheon-ro
  • Dongdaimoon-ku
  • Seoul, 130-823
  • South Korea
+82 00-0000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Asan Pharm Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC 00000 Completed Generating Revenue
1. Later Stage VC 01-Jan-1985 00000 00000 Completed Generating Revenue
To view Asan Pharm’s complete valuation and funding history, request access »

Asan Pharm Executive Team (1)

Name Title Board Seat Contact Info
Moon Hwang Chief Executive Officer
To view Asan Pharm’s complete executive team members history, request access »

Asan Pharm Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
International Finance Corporation PE/Buyout Minority 000 0000 000000 0
YFY Biotech Management Company Corporate Venture Capital Minority 000 0000 000000 0
To view Asan Pharm’s complete investors history, request access »